Greene Barry E (CIK 0001291963)

Latest company ownership

Shares held
69,000
Last filed at
May 30, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
15,875
Last filed at
Aug 14, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 16, 2020 Sep 11, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 18.8 -44,685 -12.48% ✓ $5.5M
Jul 7, 2020 Jul 9, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 10.0 -22,265 -24.47% ✓ $3.6M
May 6, 2020 May 7, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 10.0 -22,265 -24.47% ✓ $3.3M
Apr 7, 2020 Apr 9, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 90.0 +3,754 5.78% ✗ $174.3K
Oct 22, 2019 Oct 24, 2019 ALNYLAM PHARMACEUTICALS, INC. President Sell 3.8 -58,913 -47.55% ✓ $5.3M
Mar 14, 2018 Mar 16, 2018 ALNYLAM PHARMACEUTICALS, INC. President Sell 3.8 -38,460 -37.25% ✓ $5.5M
Oct 2, 2017 Oct 4, 2017 ALNYLAM PHARMACEUTICALS, INC. President Sell 2.5 -85,316 -45.25% ✓ $10.7M
Sep 20, 2017 Sep 22, 2017 ALNYLAM PHARMACEUTICALS, INC. President Sell 3.8 -76,815 -45.67% ✓ $7.7M
Dec 1, 2016 Dec 5, 2016 ALNYLAM PHARMACEUTICALS, INC. President Sell 5.0 -31,825 -25.85% ✓ $1.4M
May 26, 2015 May 28, 2015 ALNYLAM PHARMACEUTICALS, INC. COO Sell 3.8 -67,379 -72.17% ✓ $8.4M
Apr 2, 2015 Apr 6, 2015 Karyopharm Therapeutics Inc. Director Buy 95.0 +3,000 100.00% ✗ $87.9K
Dec 19, 2014 Dec 22, 2014 ALNYLAM PHARMACEUTICALS, INC. COO Sell 5.0 -11,200 -30.97% ✓ $1.1M
Nov 17, 2014 Nov 19, 2014 ALNYLAM PHARMACEUTICALS, INC. COO Sell 5.0 -33,200 -47.86% ✓ $3M
Nov 11, 2014 Nov 13, 2014 ALNYLAM PHARMACEUTICALS, INC. COO Sell 10.0 -11,100 -23.49% ✓ $1.1M
Feb 3, 2014 Feb 4, 2014 ALNYLAM PHARMACEUTICALS, INC. COO Sell 22.5 -1,680 -4.45% ✗ $132.2K